Skip to main content
Fig. 8 | BMC Biotechnology

Fig. 8

From: Targeted cancer therapy potential of quercetin-conjugated with folic acid-modified nanocrystalline cellulose nanoparticles: a study on AGS and A2780 cell lines

Fig. 8

Antioxidant assay. (A) The antioxidant capacity of NCC/CTAB/FA/Quercetin NPs was evaluated using ABTS and DPPH assays. ABTS inhibition reached about 97.23% at 500 µg/mL, while DPPH inhibition plateaued at 100% above 1000 µg/mL. IC50 values were 151.65 µg/mL for ABTS and 349.54 µg/mL for DPPH. (B) Glutathione achieved 100% ABTS inhibition and a DPPH plateau at 97.28%. These findings highlight the antioxidant properties of NCC/CTAB/FA/Quercetin NPs. The data is presented as mean ± standard deviation (SD), and statistical significance is denoted as * P < 0.05 and *** P < 0.001

Back to article page

BMC Biotechnology

ISSN: 1472-6750

Contact us